Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rembielak

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 22, 2019
Non-Melanoma Skin Cancer - An Underestimated Global Health Threat?A Rembielak, T Ajithkumar
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 8, 2022
Is There Still a Role for Radiation Therapy in the Management of Benign Disease?B Fionda, A Rembielak
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 24, 2020
The Evolving Practice of Palliative RadiotherapyA Rembielak, K Dennis
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 2, 2023
Function Preservation with Brachytherapy: Reviving the ArtA Rembielak, A Budrukkar, T Kron
Neoplasma|October 24, 2000
Influence of previous treatment on palliative effect of HDR brachytherapy in advanced esophageal cancerB Białas, T Rutkowski, M Fijałkowski, et al.
Neoplasma|January 27, 2010
Anaesthesia for radiation therapy - Gliwice experienceE Wojcieszek, A Rembielak, B Bialas, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 8, 2020
Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-upS H Nahm, A Rembielak, H Peach, et al.
The British Journal of Dermatology|July 22, 2014
Utility of radiotherapy for treatment of basal cell carcinoma: a reviewM Cho, L Gordon, A Rembielak, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 9, 2023
Advances in Skin Brachytherapy: Cosmesis and Function PreservationA Rembielak, G Mansy, E A Barnes, et al.
Neoplasma|July 5, 2002
Efficacy and toxicity of MDR versus HDR brachytherapy for primary vaginal cancerT Rutkowski, B Białas, A Rembielak, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 22, 2019
Non-Melanoma Skin Cancer - An Underestimated Global Health Threat?A Rembielak, T Ajithkumar
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 8, 2022
Is There Still a Role for Radiation Therapy in the Management of Benign Disease?B Fionda, A Rembielak
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 24, 2020
The Evolving Practice of Palliative RadiotherapyA Rembielak, K Dennis
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 2, 2023
Function Preservation with Brachytherapy: Reviving the ArtA Rembielak, A Budrukkar, T Kron
Neoplasma|October 24, 2000
Influence of previous treatment on palliative effect of HDR brachytherapy in advanced esophageal cancerB Białas, T Rutkowski, M Fijałkowski, et al.
Neoplasma|January 27, 2010
Anaesthesia for radiation therapy - Gliwice experienceE Wojcieszek, A Rembielak, B Bialas, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 8, 2020
Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-upS H Nahm, A Rembielak, H Peach, et al.
The British Journal of Dermatology|July 22, 2014
Utility of radiotherapy for treatment of basal cell carcinoma: a reviewM Cho, L Gordon, A Rembielak, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 9, 2023
Advances in Skin Brachytherapy: Cosmesis and Function PreservationA Rembielak, G Mansy, E A Barnes, et al.
Neoplasma|July 5, 2002
Efficacy and toxicity of MDR versus HDR brachytherapy for primary vaginal cancerT Rutkowski, B Białas, A Rembielak, et al.
Pageof 3